Evidence map›Paper›PMID 25785032›Full record

ArticleInternational journal of clinical and experimental medicine2015

Ghrelin inhibits AngII -induced expression of TNF-α, IL-8, MCP-1 in human umbilical vein endothelial cells.

Bin Deng, Fang Fang, Tianlu Yang, Zaixin Yu, Bin Zhang, Xiumei Xie

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.9field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 26 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Bin DengDepartment of Cardiology, Xiang Ya Hospital, Central South University 87 Xiang Ya Road, Changsha 410008, Hunan, P. R. China.
Fang FangDepartment of Cardiology, Xiang Ya Hospital, Central South University 87 Xiang Ya Road, Changsha 410008, Hunan, P. R. China.
Tianlu YangDepartment of Cardiology, Xiang Ya Hospital, Central South University 87 Xiang Ya Road, Changsha 410008, Hunan, P. R. China.
Zaixin YuDepartment of Cardiology, Xiang Ya Hospital, Central South University 87 Xiang Ya Road, Changsha 410008, Hunan, P. R. China.
Bin ZhangDepartment of Histololgy and Embryololgy, Xiang Ya Medical College, Central South University 172 Tongzipo Road, Changsha 410013, Hunan, P. R. China.
Xiumei XieDepartment of Geriatrics, Xiang Ya Hospital, Central South University 87 Xiang Ya Road, Changsha 410008, Hunan, P. R. China.
Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimGhrelin, a gastric peptide, is involved in several metabolic and cardiovascular processes. Emerging evidence indicates the potential involvement of ghrelin in low-grade inflammatory diseases such as atherosclerosis and hypertension. Cytokine-induced inflammation is critical in these pathological states. The growth hormone secretagogue receptor (GHSR) has been identified in blood vessels, so we predict that ghrelin might inhibit proinflammatory responses in human umbilical vein endothelial cells (HUVECs). The aim of this study is to examine the effect of ghrelin on angiotension II (AngII)-induced expression of TNF-α, MCP-1, IL-8 in HUVECs.

methodHUVECs were pretreated with ghrelin, with or without the specific antagonist of GHSR [D-Lys(3)]-GHRP-6, the selective inhibitor of nuclear factor-kappaB (NF-κB) PDTC, and the selective inhibitor of extracellular signal-regulated kinase (ERK1/2) PD98059. The cells were finally treated with AngII. The expression of TNF-α, MCP-1, IL-8 was examined by reverse transcription-polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA). The activity of ERK1/2 and NF-κB was analyzed by Western blot.

resultour study showed that ghrelin inhibited AngII -induced expression of IL-8, TNF-α and MCP-1 in the HUVECs via GHSR pathway in concentration- and time-dependent manners. We also found that ghrelin inhibited AngII -induced activation of ERK1/2 and NF-κB.

conclusionsthese results suggest that Ghrelin may play novel antiinflammatory and immunoregulatory roles in HUVECs.

Indexed as

atherosclerosisGhrelininflammationinterleukin-8monocyte chemoattractant protein-1NF-κB and MAPK pathwaystumor necrosis factor-α

Identifiers

PMID25785032
PMCPMC4358487
OpenAlexW1582408800

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.